1134
A. Jana et al. / Tetrahedron 68 (2012) 1128e1136
123.4, 120.5, 120.3, 120.1, 119.5, 79.3, 64.7, 39.9, 31.6, 28.4; FTIR (KBr,
cmꢂ1): 2927, 1722; HRMS calcd for C30H29NO4: 467.2097, found:
467.2106.
evaporation under reduced pressure and the crude residue was
purified by column chromatography with EtOAc in pet. ether as an
eluant.
4.3.3. tert-Butyl (S)-1-(((perylen-3-yl)methoxy)carbonyl) ethyl-
carbamate (4f). 3-(Bromomethyl)perylene (0.100 g, 0.29 mmol),
potassium fluoride (0.020 g, 0.34 mmol), potassium carbonate
4.4.1. Cyclohexyl (perylen-3-yl)methyl carbonate (7a). 3-(Hydrox-
ymethyl)perylene (0.100 g, 0.36 mmol), cyclohexyl chloroformate
(0.059 g, 0.36 mmol), and DMAP (0.053 g, 0.43 mmol) were used
and the reaction mixture was stirred for 6 h at room temperature.
The crude reaction mixture was purified by column chromatogra-
phy using 10% EtOAc in pet. ether to give the carbonate ester 7b
(0.112 mg, 76%) as a yellow solid, mp: 158e160 ꢄC; TLC Rf 0.60 (15%
(0.048 g, 0.34 mmol), and N-(tert-butoxycarbonyl)-L-alanine
(0.055 g, 0.29 mmol) were used. The reaction mixture was stirred
for 12 h. A deep brown solid residue obtained which on purification
by column chromatography using 30% EtOAc in pet. ether gave
compound 4f (0.099 mg, 75%) as a yellow solid, mp: 144e147 ꢄC;
TLC Rf 0.30 (15% EtOAc in pet. ether); 1H NMR (CDCl3, 200 MHz):
EtOAc in pet. ether); 1H NMR (CDCl3, 200 MHz):
d
¼8.23e8.10 (m,
4H), 7.86 (d, J¼8.2 Hz, 1H), 7.69 (d, J¼8.0 Hz, 2H), 7.58e7.43 (m, 4H),
d
¼8.24e8.11 (m, 4H), 7.79 (d, J¼8.2 Hz, 1H), 7.69 (d, J¼8.2 Hz, 2H),
5.54 (s, 2H), 4.71e4.62 (m,1H),1.98e1.26 (m, 10H); 13C NMR (CDCl3,
7.58e7.44 (m, 4H), 5.55 (dd, J¼12.4, 7.6 Hz, 2H), 5.08 (s, NH), 4.38 (t,
50 MHz):
d
¼154.9, 134.7, 133.1,132.5,131.9,131.2,130.9,130.6,129.1,
J¼6.8 Hz, 1H), 1.43 (s, 9H), 1.38 (d, J¼7.2 Hz, 3H); 13C NMR (CDCl3,
128.5, 128.3, 128.1, 127.3, 126.7, 123.4, 120.7, 120.5, 119.7, 72.8, 67.74,
31.7, 25.4, 23.9; FTIR (KBr, cmꢂ1): 1734; HRMS calcd for C28H24O3:
408.1725, found: 408.1727.
100 MHz):
d¼173.3, 155.0, 134.5, 132.8, 132.3, 131.8, 130.9, 130.7,
130.3, 128.9, 128.4, 128.3, 128.2, 128.0, 127.9, 127.1, 126.6, 126.5,
123.1, 120.6, 120.5, 120.3, 119.5, 79.8, 65.5, 49.3, 28.2, 18.6; FTIR (KBr,
cmꢂ1): 2924, 1711; HRMS calcd for C29H27NO4: 453.1940, found:
453.1948.
4.4.2. 2-Isopropyl-5-methylcyclohexyl (perylen-3-yl)methyl carbon-
ate (7b). 3-(Hydroxymethyl)perylene (0.100 g, 0.36 mmol), men-
thol chloroformate (0.079 g, 0.36 mmol), and DMAP (0.053 g,
0.43 mmol) were used and the reaction mixture was stirred for 8 h
at room temperature. The crude reaction mixture was purified by
column chromatography using 10% EtOAc in pet. ether to give the
4.3.4. tert-Butyl (S)-1-(((perylen-3-yl)methoxy)carbonyl)-2-
phenylethylcarbamate (4g). 3-(Bromomethyl)perylene (0.100 g,
0.29 mmol), potassium fluoride (0.020 g, 0.34 mmol), potassium
carbonate (0.048 g, 0.34 mmol), and N-(tert-butoxycarbonyl)-
L
-
carbonate ester 7c (0.125 mg, 75%) as
132e135 ꢄC; TLC Rf 0.72 (15% EtOAc in pet. ether); 1H NMR (CDCl3,
200 MHz):
a yellow solid, mp:
phenylalanine (0.077 g, 0.29 mmol) were used. The reaction mix-
ture was stirred for 12 h. The crude reaction mixture was purified
by column chromatography using 25% EtOAc in pet. ether to give
d
¼8.17e8.05 (m, 4H), 7.79 (d, J¼8.4 Hz, 1H), 7.64 (d,
J¼8.2 Hz, 2H), 7.52e7.39 (m, 4H), 5.51 (s, 2H), 4.62e4.49 (m, 1H),
2.10e1.88 (m, 3H), 1.67e1.60 (2H), 1.40 (m, 1H), 1.11e0.994 (m, 3H),
0.89e0.83 (m, 6H), 0.76 (d, J¼7.0 Hz, 3H); 13C NMR (CDCl3,
ester conjugate 4g (0.121 mg, 79%) as
147e150 ꢄC; TLC Rf 0.30 (15% EtOAc in pet. ether); 1H NMR (CDCl3,
200 MHz):
a yellow solid, mp:
d
¼8.28e8.18 (m, 3H), 8.12 (d, J¼7.8 Hz, 1H), 7.76e7.68
50 MHz):
d
¼155.0, 134.5, 132.8, 132.2, 131.7, 131.0, 130.8, 130.4,
(m, 3H), 7.56e7.45 (m, 4H), 7.14 (s, 3H), 6.98 (s, 2H), 5.52 (dd,
J¼12.4, 4.0 Hz, 2H), 4.98 (d, J¼8.8 Hz, NH), 4.659e4.629 (m, 1H),
3.05 (d, J¼5.4 Hz, 2H), 1.39 (s, 9H); 13C NMR (CDCl3, 50 MHz):
128.9, 128.4, 128.1, 127.9, 127.0, 126.5, 123.2, 120.5, 120.3, 119.5, 78.8,
67.7, 47.1, 40.8, 34.1, 31.5, 26.1, 23.4, 22.0, 20.7, 16.3; FTIR (KBr,
cmꢂ1): 1736; HRMS calcd for C32H32O3: 464.2351, found: 464.2348.
d
¼171.9, 154.8, 135.8, 134.6, 133.0, 132.5, 131.9, 131.0, 130.8, 130.2,
129.3, 129.0, 128.7, 128.5, 128.3, 128.1, 127.2, 126.9, 126.7, 123.3,
120.6, 120.4, 119.5, 79.9, 65.5, 54.5, 38.4, 28.3; FTIR (KBr, cmꢂ1):
2925, 1733; HRMS calcd for C35H31NO4: 529.2253, found: 529.2368.
4.4.3. (8S,9S,10R,13R,14S,17R)-2,3,4,7,8,9,10,11,12,13,14,15,16,17-
Tetradecahydro-10,13-dimethyl-17-((R)-6-methylheptan-2-yl)-1H-
cyclopenta[a]phenanthren-3-yl
(perylen-3-yl)methyl
carbonate
(7c). 3-(Hydroxymethyl)perylene (0.100 g, 0.36 mmol), cholesterol
chloroformate (0.162 g, 0.36 mmol), and DMAP (0.053 g,
0.43 mmol) were used and the reaction mixture was stirred for 6 h
at room temperature. The crude reaction mixture was purified by
column chromatography using 10% EtOAc in pet. ether to give the
4.3.5. tert-Butyl(S)-1-(((perylen-3-yl)methoxy)carbonyl)-2-(1H-in-
dol-3-yl)ethylcarbamate (4h). 3-(Bromomethyl)perylene (0.100 g,
0.29 mmol), potassium fluoride (0.020 g, 0.34 mmol), potassium
carbonate (0.048 g, 0.34 mmol), and N-(tert-butoxycarbonyl)-L-
tryptophan (0.088 g, 0.29 mmol) were used. The reaction mixture
was stirred for 12 h. The crude reaction mixture was purified by
column chromatography using 30% EtOAc in pet. ether to give
caged ester 4h (0.135 mg, 82%) as a yellow solid, mp: 162e164 ꢄC; Rf
0.50 (30% EtOAc in pet. ether); 1H NMR (CDCl3, 200 MHz):
carbonate ester 7d (0.198 mg, 79%) as
168e170 ꢄC; TLC Rf 0.72 (15% EtOAc in pet. ether); 1H NMR (CDCl3,
200 MHz):
J¼8.0 Hz, 2H), 7.55e7.40 (m, 4H), 5.51 (s, 2H), 5.35 (d, J¼4.0 Hz, 1H),
4.59e4.43 (m, 1H), 2.39e2.34 (m, 2H), 1.98e1.09 (m, 23H), 0.95 (s,
6H), 0.89e0.82 (m, 9H), 0.63 (s, 3H); 13C NMR (CDCl3, 50 MHz):
a yellow solid, mp:
d
¼8.20e8.08 (m, 4H), 7.83 (d, J¼8.4 Hz, 1H), 7.66 (d,
d
¼8.27e8.16 (m, 3H), 8.11 (d, J¼7.6 Hz, 1H), 7.75e7.60 (m, 3H),
7.52e7.34 (m, 4H), 7.20e7.06 (m, 4H), 6.69 (s, 1H), 5.48 (dd, J¼12.2,
6.2 Hz, 2H), 5.11 (s, 1H), 4.74 (m, 1H), 3.27 (d, J¼5.0 Hz, 2H), 1.42 (s,
d
¼154.6, 139.3, 134.5, 132.8, 132.2, 131.6, 130.9, 130.7, 130.2, 128.8,
128.4,128.2,127.9,127.0,126.5,123.2,122.9,120.5,120.2,119.4, 78.2,
71.8, 67.6, 56.6, 56.1, 49.9, 42.3, 39.7, 39.5, 38.1, 36.8, 36.5, 36.2, 35.8,
31.81, 28.2, 28.0, 27.7, 24.3, 23.9, 22.9, 22.6, 21.0, 19.2, 18.7; FTIR
(KBr, cmꢂ1): 1741; HRMS calcd for C49H58O3: 694.4386, found:
694.4388.
9H), 13C NMR (CDCl3, 50 MHz):
d¼172.3, 155.2, 136.0, 134.6, 132.9,
132.2, 131.7, 131.0, 130.8, 130.3, 129.6, 128.98, 128.5, 128.2, 128.0,
127.6, 127.1, 126.6, 123.2, 122.8, 122.1, 120.6, 120.3, 119.6, 119.5, 118.7,
111.1, 109.9, 79.9, 65.4, 54.4, 29.9, 28.3; FTIR (KBr, cmꢂ1): 2926,
1706; HRMS calcd for C37H32N2O4: 568.2362, found: 568.2479.
4.4.4. (Perylen-4-yl)methyl phenyl carbonate (7d). 3-(Hydrox-
ymethyl)perylene (0.100 g, 0.36 mmol), phenyl chloroformate
(0.056 g, 0.36 mmol), and DMAP (0.053 g, 0.43 mmol) were used
and the reaction mixture was stirred for 10 h at room temperature.
The crude reaction mixture was purified by column chromatogra-
phy using 15% EtOAc in pet. ether to give the carbonate ester 7e
(0.119 mg, 82%) as a yellow solid, mp: 130e132 ꢄC; TLC Rf 0.48 (15%
4.4. General procedure for the synthesis of caged carbonates
(7aed)
3-(Hydroxymethyl)perylene (1 equiv) was dissolved in dry DCM
(5 ml), and to the solution corresponding alcohol chloroformate
(1 equiv) was added followed by 1.2 equiv of N,N-dimethylpyridin-
4-amine (DMAP). The reaction mixture was stirred at room tem-
perature for 8e10 h. The solvent was removed by rotary
EtOAc in pet. ether); 1H NMR (CDCl3, 200 MHz):
4H), 7.88 (d, J¼8.2 Hz, 1H), 7.67 (d, J¼8.0 Hz, 2H), 7.63e7.15 (m, 9H),
d
¼8.22e8.09 (m,